Clinical trial
ABSORB FIRST Registry: An International Post-market Registry of Patients With de Novo Lesions in Previously Untreated Vessels Treated With Absorb Bioresorbable Vascular Scaffold (Absorb BVS).
NCT01759290 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ABSORB FIRST Registry: An International Post-market Registry of Patients With de Novo Lesions in Previously Untreated Vessels Treated With Absorb Bioresorbable Vascular Scaffold (Absorb BVS).
- Lead sponsor
- Abbott Medical Devices
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- December 31, 2015
- Enrollment
- 1,800 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic total occlusion of coronary artery, coronary artery disease, coronary artery restenosis, coronary artery stenosis, coronary disease, coronary occlusion, coronary restenosis